Suet Chung Yeung

TL;DR: In this paper, the authors provide indoleamine 2,3 -dioxygenase 1 (IDO1) inhibitors of Formula I: or pharmaceutically acceptable salts thereof, in which X, L, n, m, R 1, R 2a, R 2b, R n, R m, and R 1 are as defined as defined in this paper.

TL;DR: The present disclosure relates generally to certain 6-azabenzimidazole compounds, pharmaceutical compositions comprising said compounds, and methods of making and using said compounds and pharmaceutical compositions as mentioned in this paper.

TL;DR: The present disclosure relates generally to certain 6-azabenzimidazole compounds, pharmaceutical compositions comprising said compounds, and methods of making and using said compounds and pharmaceutical compositions as mentioned in this paper.

TL;DR: The present disclosure provides indoleamine 2,3-dioxygenase 1 (IDOL) inhibitors of Formula I: or pharmaceutically acceptable salts thereof as discussed by the authors.

TL;DR: In this paper, a compound of Formula (I): or a pharmaceutically acceptable salt thereof as described herein is provided, as well as pharmaceutical compositions comprising a compound, processes for preparing compounds of Formula, and therapeutic methods for treating inflammatory disease.